EDGAR Filing Documents for 0001683168-22-002143

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001683168-22-002143

Filing Date

2022-03-30

Accepted

2022-03-30 17:20:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sunshinebio_s3.htm	S-3	148797
2	GRAPHIC	image_001.jpg	GRAPHIC	7392
3	OPINION OF ANDREW I. TELSEY, P.C.	sunshinebio_ex0501.htm	EX-5.1	12906
4	CONSENT OF B F BORGERS CPA PC	sunshinebio_ex2301.htm	EX-23.1	2184
5	CALCULATION OF REGISTRATION FEE	sunshinebio_ex107.htm	EX-FILING FEES	9551
6	GRAPHIC	image_002.jpg	GRAPHIC	6310
7	GRAPHIC	image_003.jpg	GRAPHIC	6733
	Complete submission text file	0001683168-22-002143.txt		203256

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)